Adjuvant interferon therapy in high-risk melanoma: For which patients? [Adjuvante Interferontherapie beim Hochrisikomelanom : Welche Patienten kommen in Frage?]

被引：0
|
作者：
Hauschild A. [1 ,2 ]
Kähler C. [1 ]
机构：
[1] Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Kiel
[2] Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, 24105 Kiel
来源：
best practice onkologie | 2007年 / 2卷 / 2期
关键词：
D O I：
10.1007/s11654-007-0014-7
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：4 / 13
页数：9
相关论文
共 50 条
  • [1] Update on adjuvant interferon therapy for high-risk melanoma
    Agarwala, SS
    Kirkwood, JM
    ONCOLOGY-NEW YORK, 2002, 16 (09): : 1177 - 1187
  • [2] Adjuvant high-dose interferon therapy for high-risk melanoma
    Ready, N
    Weinstock, MA
    ARCHIVES OF DERMATOLOGY, 2003, 139 (12) : 1635 - 1637
  • [3] ADJUVANT THERAPY OF HIGH-RISK MALIGNANT-MELANOMA PATIENTS WITH GAMMA-INTERFERON
    LANDTHALER, M
    BRAUNFALCO, O
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (04) : 687 - 688
  • [4] Adjuvant strategies for high-risk melanoma [Adjuvante strategien bei hochrisikomelanomen]
    Fluck M.
    Garbe C.
    Der Onkologe, 2014, 20 (6): : 555 - 567
  • [5] Systemic adjuvant therapy for patients with high-risk melanoma
    Tsai, Kenneth Y.
    ARCHIVES OF DERMATOLOGY, 2007, 143 (06) : 779 - 782
  • [6] High-risk surgically resected pediatric melanoma and adjuvant interferon therapy
    Chao, MM
    Schwartz, JL
    Wechsler, DS
    Thornburg, CD
    Griffith, KA
    Williams, JA
    PEDIATRIC BLOOD & CANCER, 2005, 44 (05) : 441 - 448
  • [7] Adjuvant therapy for patients with high-risk malignant melanoma
    McClay, EF
    SEMINARS IN ONCOLOGY, 2002, 29 (04) : 389 - 399
  • [8] Adjuvant Therapy for High-Risk Melanoma
    Tarhini, Ahmad A.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2014, 10 (05) : 4 - 13
  • [9] Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain
    González-Larriba, JL
    Serrano, S
    Alvarez-Mon, M
    Camacho, F
    Casado, MA
    Díaz-Pérez, JL
    Díaz-Rubio, E
    Fosbrook, L
    Guillem, V
    López-López, JJ
    Moreno-Nogueira, JA
    Toribio, J
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (18) : 2344 - 2352
  • [10] Adjuvant Interferon in High-Risk Melanoma: End of the Era?
    Janku, Filip
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) : E15 - E16
12345